Managers / Q1 2026
WASHINGTON UNIVERSITY
CIK 0000903603 · CAMPUS BOX NUMBER 1058, ONE BROOKINGS DRIVE, ST LOUIS, MO, 63130-4899 · 314-935-5152
Summary
Washington University reported $160M in U.S.-listed holdings across 2 positions for Q1 2026.
The portfolio is heavily concentrated: Nu alone accounts for 94.8% of reported value.
Compared with Q4 2025, the fund opened 0 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 94.8% · $152M
- Common Stock · 5.2% · $8M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MRNAMODERNA INC | SOLD OUT | −150.0K | 0 | −$4M | $0 |
| RBRKRUBRIK INC | SOLD OUT | −50.5K | 0 | −$4M | $0 |
| FIGFIGMA INC | SOLD OUT | −26.5K | 0 | −$992,061 | $0 |
| NU HOLDINGS LTD | HELD | +0 | 10.57M | −$25M | $152M |
| MAZEMAZE THERAPEUTICS INC | HELD | +0 | 280.8K | −$3M | $8M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | NU HOLDINGS LTD | ORD SHS CL A | 94.77% | $152M | 10.57M |
| 2 | MAZEMAZE THERAPEUTICS INChistory → | COM | 5.23% | $8M | 280.8K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $160M | 2 | May 6, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $198M | 5 | Jan 16, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $179M | 3 | Nov 3, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $121M | 4 | Jul 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $111M | 2 | May 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $118M | 3 | Jan 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $154M | 4 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $220M | 3 | Aug 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $270M | 5 | Apr 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $203M | 4 | Jan 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $278M | 10 | Nov 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $267M | 6 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 11 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 7 | Jan 30, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $296M | 7 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $270M | 11 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $277M | 7 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $357M | 6 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $344M | 6 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $280M | 5 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $116M | 3 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $134M | 2 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.